Mazdutide

Mazdutide, also known as IBI362 and LY3305677, is a co-agonist at the GLP-1 and glucagon receptors, derived from oxyntomodulin. Oxyntomodulin is a naturally occurring proglucagon product that already activates both receptors, so the engineering problem here was extending its half-life and tuning the potency ratio, rather than creating dual activity from a single-receptor parent. The analogue is acylated for albumin binding and a long half-life.

The receptor pairing looks contradictory at first, since glucagon raises blood glucose while GLP-1 lowers it. The resolution is that glucagon also increases energy expenditure and hepatic fat oxidation. In the right ratio, the GLP-1 arm offsets the glycaemic effect while the glucagon arm contributes the additional expenditure. That origin also distinguishes it from GIP-containing dual agonists, whose second receptor is a second incretin rather than a counter-regulatory hormone.

Research centres on the balance between the two arms. Too much glucagon activity and glycaemic control suffers; too little and the compound is simply a GLP-1 agonist with extra complexity. The literature on this class is largely a literature about getting that ratio right. Hepatic lipid content is a frequent endpoint because the glucagon arm acts directly on the liver.

For a laboratory, the useful property is that mazdutide allows the glucagon receptor contribution to be probed in a molecule where the GLP-1 arm is present to offset it, which single-agent glucagon does not permit. Comparing a dual agonist against single agonists is the standard way to establish whether an effect requires both receptors. Strands cover receptor selectivity and potency ratios, hepatic lipid metabolism, energy expenditure, and the pharmacology of albumin-bound acylated peptides. Published work is indexed on PubMed.

Supplied lyophilised. As an acylated long-acting analogue it is stable dry and aggregation-prone in solution, with agitation and freeze-thaw cycling the two things most likely to spoil a preparation. The acyl chain also makes apparent solubility concentration-dependent, which is worth establishing before a quantitative assay rather than during one.

Swirl rather than shake, keep solutions cold in small working volumes, prepare them fresh, and discard any that has gone turbid. The sealed powder is stored at -20°C. Solvent options are under reconstitution supplies.